Researchers at Broad Institute and MIT engineer “Cas9” animal models to study disease and inform drug discovery

Researchers from the Broad Institute and Massachusetts Institute of Technology have created a new mouse model to simplify application of the CRISPR-Cas9 system for in vivo genome editing experiments. …read more

Source: Cancer